Form 4: Emergent BioSolutions Director Kathryn C. Zoon Sells 10,000 Shares
SEC Form 4 Filing
Director Kathryn C. Zoon of Emergent BioSolutions Inc. (EBS) sold 10,000 shares of common stock at a price of $5.73 per share on March 12, 2025.
Summary
- On March 12, 2025, Kathryn C. Zoon, a director of Emergent BioSolutions Inc., sold 10,000 shares of the company's common stock.
- The transaction was executed at a price of $5.73 per share.
- Following the sale, Zoon directly owns 44,482 shares of Emergent BioSolutions Inc.
Sentiment
Score: 5
Explanation: The document is a neutral report of a stock sale by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of a transaction by a company insider and provides transparency to the market regarding the trading activities of key individuals within Emergent BioSolutions.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, potentially leading to concerns about the director's confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of transaction: Kathryn C. Zoon sold 10,000 shares of Emergent BioSolutions Inc. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.